Betamethasone Dipropionate Ointment
»Betamethasone Dipropionate Ointment contains an amount of betamethasone dipropionate (C28H37FO7)equivalent to not less than 90.0percent and not more than 110.0percent of the labeled amount of betamethasone (C22H29FO5),in a suitable ointment base.
Packaging and storage
Preserve in collapsible tubes or tight containers.Store at 25
![]() ![]() ![]()
Thin-layer chromatographic identification test á201ñ
Test solution
Transfer about 1.5g of Ointment to a glass-stoppered,50-mLcentrifuge tube.Add 15mLof methanolhydrochloric acid solution prepared by mixing 1volume of dilute hydrochloric acid (1in 120)with 4volumes of methanol.Shake to obtain a homogeneous mixture.Add 30mLof solvent hexane,mix for 10minutes,and centrifuge.Using a suitable syringe,transfer the lower aqueous phase to a second centrifuge tube,add about 20mLof water,and mix.Extract this aqueous mixture with chloroform by shaking,centrifuging,and removing the lower,chloroform phase with a syringe.Evaporate the chloroform on a steam bath with the aid of a stream of nitrogen to dryness,cool,and dissolve the residue in chloroform to obtain a solution containing about 150µg of betamethasone dipropionate per mL.
Standard solution:
USP Betamethasone Dipropionate RSin chloroform containing 150µg per mL.
Application volume:
40µL.
Developing solvent system:
a mixture of chloroform and acetone (7:1).
Procedure
Proceed as directed in the chapter.
Minimum fill á755ñ:
meets the requirements.
Assay
Internal standard solutionand Standard preparation
Prepare as directed in the Assayunder Betamethasone Dipropionate Cream,except to use alcohol containing acetic acid (1in 1000)as the solvent.
Assay preparation
Transfer an accurately weighed quantity of Ointment,equivalent to about 2mg of betamethasone dipropionate,to a capped 50-mLcentrifuge tube.Add 5.0mLof Internal standard solutionand 10.0mLof alcohol containing acetic acid (1in 1000).Heat in a water bath at 70
![]()
Auxiliary Information
Staff Liaison:Clydewyn M.Anthony,Ph.D.,Scientist
Expert Committee:(PA1)Pharmaceutical Analysis 1
USP28NF23Page 248
Pharmacopeial Forum:Volume No.29(5)Page 1430
Phone Number:1-301-816-8139
|